financetom
Business
financetom
/
Business
/
CoreWeave Shares Are Trading Lower Thursday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CoreWeave Shares Are Trading Lower Thursday: What's Going On?
Aug 14, 2025 8:58 AM

CoreWeave, Inc. ( CRWV ) shares are trading lower Thursday on continued weakness after the company reported mixed second quarter financial results on Tuesday.

What To Know: CoreWeave ( CRWV ) reported an adjusted loss of 27 cents per share, missing the consensus estimate of a 17 cent-loss. In addition, the company reported sales of $1.21 billion, beating the consensus estimate of $1.08 billion.

Product revenue rose sharply in the quarter, supported by key customer wins across AI labs, hyperscalers and enterprises. Notable deals included a $4 billion expansion with OpenAI and new agreements with BT Group, Cohere, LG CNS, and Mistral. The company also brought its first NVIDIA GB200 NVL72 systems online for customers at scale and delivered the largest-ever MLPerf Training submission using Blackwell GB200 instances.

CoreWeave ( CRWV ) completed its acquisition of Weights & Biases during the quarter and launched new tools to extend its cloud platform capabilities. These included Mission Control Integration for real-time cluster health management, W&B Inference for exploring open-source AI models and W&B Weave Online Evaluations for monitoring AI agents in production.

Operating income totaled $19.2 million, representing a 2% margin. Net loss narrowed to $290.5 million, or $0.60 per share, from $323 million, or $1.62 per share, in the same period last year.

FY25 Outlook: The company sees sales from $5.15 billion to $5.35 billion, versus the consensus estimate of $5.03 billion.

Q3 Outlook: CoreWeave ( CRWV ) expects sales from $1.26 billion to $1.30 billion, versus the consensus estimate of $1.25 billion.

Analyst Changes: Following the earnings report, multiple analysts issued price target adjustments.

Stifel analyst Ruben Roy maintained a Hold rating on CoreWeave ( CRWV ) and raised the price target from $115 to $120.

Wells Fargo analyst Michael Turrin maintained an Equal-Weight rating on CoreWeave ( CRWV ) and raised the price target from $60 to $105.

Macquarie analyst Paul Golding maintained a Neutral rating on CoreWeave ( CRWV ) and raised the price target from $65 to $115.

B of A Securities analyst Brad Sills maintained a Neutral rating on CoreWeave ( CRWV ) and lowered the price target from $185 to $168.

Related Link: Why Advance Auto Parts Stock Is Falling Today

CRWV Price Action: At the time of publication, CoreWeave ( CRWV ) stock is trading 10.8% lower at $105.04, according to data from Benzinga Pro.

Image via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UAW says workers at VW Tennessee plant file for union election
UAW says workers at VW Tennessee plant file for union election
Mar 18, 2024
WASHINGTON, March 18 (Reuters) - The United Auto Workers said Monday that workers at Volkswagen's Chattanooga, Tennessee, assembly plant are seeking an election to unionize, setting up a critical test for UAW President Shawn Fain's unprecedented campaign to expand the union's reach to foreign-owned automakers in the southern United States. The UAW said a supermajority of eligible workers at the...
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
Mar 18, 2024
Friday, the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted positively (8-3) favoring expanded use of Bristol Myers Squibb & Co ( BMY )  2seventy bio Inc’s  Abecma (idecabtagene vicleucel). The panel said Abecma demonstrated a favorable benefit/risk profile for patients with triple-class exposed relapsed or refractory multiple myeloma based on the pivotal Phase 3 KarMMa-3 study results, including the key secondary endpoint of overall...
RBC Capital Markets Notes Imperial Oil's Pipeline Maintenance In Winnipeg
RBC Capital Markets Notes Imperial Oil's Pipeline Maintenance In Winnipeg
Mar 18, 2024
10:18 AM EDT, 03/18/2024 (MT Newswires) -- RBC Capital Markets noted over the weekend Imperial Oil Ltd. ( IMO ) 's decision to implement temporary transportation measures to maintain regular fuel supplies to the Winnipeg region following unplanned pipeline maintenance in the area. The pipeline will be out of service for three months starting mid-March, RBC said. The company will...
Apple to Reinforce Artificial Intelligence Strategy with Potential Google Partnership, Wedbush Says
Apple to Reinforce Artificial Intelligence Strategy with Potential Google Partnership, Wedbush Says
Mar 18, 2024
10:17 AM EDT, 03/18/2024 (MT Newswires) -- Apple's ( AAPL ) potential partnership with Google ( GOOG ) parent company Alphabet (GOOG, GOOGL) is part of the iPhone maker's strategy to incorporate artificial intelligence into its flagship product, Wedbush Securities said. The technology giants are in talks for Apple ( AAPL ) to license Google's ( GOOG ) Gemini AI...
Copyright 2023-2026 - www.financetom.com All Rights Reserved